Podcasts about BTK

Jake and Romy Reiner are done. Sources close to the family told TMZ directly: "Nick's defense is Nick's defense. They're not involved." The high-profile defense attorney they initially funded—Alan Jackson, known for winning the Karen Read acquittal—withdrew from the case in January. Nick Reiner now has a public defender. Reports indicate his siblings won't attend the trial. In over two months of incarceration, his only visitor has been his lawyer. This Hidden Killers Week In Review examines what brought two siblings to this point—and what his not guilty plea actually signals.Nick Reiner pleaded not guilty to two counts of first-degree murder with special circumstances in the December 14th stabbing deaths of his parents, Rob Reiner and Michele Singer Reiner, at their Brentwood home. But that plea wasn't a claim of innocence. It was a procedural placeholder keeping all defense options open.In California, pursuing an insanity defense requires a dual plea. The single not guilty keeps doors open while psychiatric evaluations continue. Door one: full insanity under M'Naghten—a longshot given Nick was arguing with his father at a party hours before the killings. Door two: diminished actuality using his schizoaffective disorder to argue he couldn't form specific intent. Door three: incompetence to stand trial.After eighteen rehabs, a conservatorship, and years of police visits to the family home, what does it cost to finally stop holding on? Tony Brueski examines what three other families can teach us. Peter Lanza walked away from Adam after Sandy Hook. The Roof family went silent after Charleston. Kerri Rawson had to grieve BTK as two separate losses.The question isn't whether Jake and Romy were right to step back. It's what it cost them to hold on this long.The death penalty remains on the table.Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1Instagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodThis publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.#NickReiner #RobReiner #MicheleReiner #JakeReiner #RomyReiner #InsanityDefense #Parricide #FamilyOfKillers #HiddenKillers #TrueCrime

I'm joined by friend of the show Sunny to discuss church culture, family conflict, and secret lives in The Clovehitch Killer.We're also chatting about Dennis Rader, the BTK killer, and why we're drawn to true crime stories.Listen:Light & Shadow: True CrimeWatch:BTK: Confession Of A Serial KillerRead:Morbidly Curious by Coltan Scrivner, PhD

The Nick Reiner murder case reached a new turning point when siblings Jake and Romy Reiner — children of the late Rob and Michele Singer Reiner — officially distanced themselves from Nick's defense following his not guilty plea on February 23rd, 2026.Nick Reiner, 32, faces two counts of first-degree murder with special circumstances in the December 14th, 2025 stabbing deaths of his parents at their Brentwood, California home. He is held without bail. The Los Angeles County District Attorney's office has not ruled out the death penalty. His next hearing is April 29th, 2026.Sources with direct knowledge told TMZ that Jake and Romy no longer plan to fund a private defense attorney — and that they will not attend the trial. The family had previously hired prominent defense attorney Alan Jackson, who withdrew in January citing circumstances he said were legally and ethically impossible to disclose. Public defender Kimberly Greene is now Nick's sole legal representation. In more than two months of incarceration, she is reportedly the only person who has visited him.True Crime Today's Tony Brueski examines the legal and personal implications of the family's decision, and places it alongside three high-profile cases where families made the same impossible choice: Peter Lanza after Sandy Hook, the family of Charleston church shooter Dylann Roof, and Kerri Rawson — daughter of BTK killer Dennis Rader — who processed her grief in a memoir that reframed what it means to love someone who turns out to be capable of something monstrous.With the death penalty on the table and a preliminary hearing to be scheduled April 29th, the Reiner case is far from over. But for Jake and Romy, it may already be.Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1Instagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodThis publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.#NickReiner #RobReiner #TrueCrimeToday #RobReinerMurder #NickReinerTrial #ReinerfamilyMurder #JakeRomyReiner #NickReinerDefense #MicheleReiner #TrueCrime

Nick Reiner — son of legendary director Rob Reiner and photographer Michele Singer Reiner — pleaded not guilty on February 23rd, 2026 to two counts of first-degree murder with special circumstances in the December 14th, 2025 stabbing deaths of his parents at their Brentwood, California home. He is held without bail. The death penalty remains on the table. And his siblings, Jake and Romy Reiner, are done.Sources close to the family told TMZ directly: "Nick's defense is Nick's defense. They're not involved." The high-profile defense attorney they initially funded, Alan Jackson — known for winning the Karen Read acquittal — withdrew from the case in January. Nick now has a public defender. Reports indicate Jake and Romy will not attend the trial. In over two months of incarceration, his only visitor has been his lawyer, Kimberly Greene.Tony Brueski examines what brought two siblings to this point — after eighteen rehabs, a conservatorship, years of police visits to the family home, and a lifetime of absorbing Nick's behavior — and what three other families can teach us about the moment when holding on finally becomes impossible.Peter Lanza walked away from Adam after Sandy Hook and said publicly he wished his son had never been born. The Roof family went largely silent after Dylann Roof murdered nine people at Emanuel AME Church in Charleston. Kerri Rawson had to grieve BTK killer Dennis Rader as two separate losses — the father she loved and the monster he was.The question this episode asks isn't whether Jake and Romy were right to step back. It's what it cost them to hold on this long — and what the rest of us can learn from the families who finally stopped.Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1Instagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodThis publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.#NickReiner #RobReiner #RobReinerMurder #NickReinerTrial #ReinerfamilyMurder #JakeRomyReiner #NickReinerDefense #TrueCrime #HiddenKillers #MicheleReiner

Below-the-knee (BTK) arterial disease remains one of the more challenging areas in vascular care, particularly in patients with chronic limb-threatening ischemia (CLTI), where heavy calcification complicates endovascular treatment. As new calcium-modifying technologies emerge, an important question remains: what evidence supports their use in BTK interventions? In this episode of BackTable Vascular & Interventional, host Dr. Sabeen Dhand speaks with vascular surgeon Dr. Paul Foley of Doylestown Health about the Disrupt BTK II clinical trial from Shockwave Medical, which evaluates the performance of peripheral intravascular lithotripsy (IVL) in heavily calcified BTK disease. --- This podcast is supported by: Shockwave Medicalhttps://shockwavemedical.com/ --- SYNPOSIS Dr. Foley begins by outlining his training and the evolution of his vascular surgery practice, setting the stage for a broader discussion on how BTK interventions have changed over the past decade. The conversation explores shifts in access strategies, procedural approaches, and the unique characteristics of calcification encountered in CLTI. Because BTK calcium differs from calcification seen elsewhere in the peripheral vasculature, imaging and device selection play a particularly important role when planning IVL-based therapies. Dr. Foley reviews the design and outcomes of the Disrupt BTK II trial, where devices such as the Shockwave M5+ and S4 catheters were used to modify calcified plaque, demonstrating encouraging safety and performance signals. The discussion then turns to emerging technologies, including Shockwave's Javelin catheter, designed to deliver focused pressure waves to fracture dense calcium within peripheral arteries. Dr. Foley describes how the device fits into BTK workflows, including technique considerations and its use alongside adjunctive therapies such as balloon angioplasty. The episode also addresses the ongoing skepticism surrounding IVL in BTK disease, emphasizing the need for careful patient selection, procedural precision, and continued multidisciplinary collaboration as the field works to refine treatment strategies and improve outcomes for patients with peripheral artery disease (PAD). --- TIMESTAMPS 00:00 - Introduction08:20 - Evolution of Below-the-Knee Treatments11:10 - Differences in BTK Calcification13:13 - Imaging and Technology in BTK Interventions15:18 - Disrupt BTK II Trial Data and Results23:17 - Introduction to the Javelin Device26:39 - Technique Considerations with Javelin28:36 - Comparing Javelin and E831:17 - Future Directions for Lithotripsy Technology35:30 - Skepticism Around IVL in BTK Disease38:47 - Final Thoughts --- RESOURCES Disrupt BTK II Trialhttps://www.jvascsurg.org/article/S0741-5214(24)02063-9/fulltext

A deleted file recovered from Rex Heuermann's basement allegedly contains the Long Island Serial Killer's step-by-step methodology. According to prosecutors, eighty-seven details match how the Gilgo Beach victims were killed.The document—titled HK2002-04—was found on one of fifty-eight hard drives seized from the Massapequa Park home. Created in 2000 and modified through 2002, it allegedly contained sections for supplies, body preparation, and "lessons learned."According to court documents: A "Supplies" section allegedly listed cutting tools, acid, tarps, and cat litter. A "Body Prep" section allegedly stated: "remove head and hands, remove ID marks like tattoos." A "Things to Remember" section allegedly contained: "Hit harder... light rope broke under stress." The document allegedly referenced specific pages in FBI profiler John Douglas's Mindhunter.Jessica Taylor's remains were found along Ocean Parkway with her head removed and tattoos mutilated. DA Ray Tierney stated: "The exact method by which these murders were committed in excruciating detail in that document is in some cases identical to the methodology used to murder the victims."Twenty-seven years under the same roof produced two completely opposite conclusions. Rex Heuermann's wife Asa Ellerup still calls him her "hero" and described jail visits as feeling like "a first date." Their daughter Victoria says he's "most likely the Gilgo Beach serial killer" after speaking with BTK's daughter about having an alleged killer for a father.According to prosecutors, female hairs found on multiple victims were allegedly consistent with DNA from both women. Neither is accused of involvement—the transfer allegedly came from Rex's clothing or their home.The daughter saw what the wife cannot. Both are victims of different truths.Rex Heuermann has pleaded not guilty to all charges. Trial is September 2026.Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1Instagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodThis publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.#RexHeuermannNews #GilgoBeachKiller #LISK #LongIslandSerialKiller #GilgoBeachMurders #LISKDocument #VictoriaHeuermann #AsaEllerup #SuffolkCounty #TrueCrimeToday

Forensic analysts recovered a deleted file from Rex Heuermann's basement. According to prosecutors, it's the Long Island Serial Killer's planning document for murder.The document—titled HK2002-04—was hidden on one of fifty-eight hard drives seized from the Massapequa Park home. Created in 2000, modified through 2002, it allegedly contained eighty-seven details prosecutors say match the methodology used on the Gilgo Beach victims. A "Supplies" section allegedly listed cutting tools, acid, tarps, and cat litter. A "Body Prep" section allegedly stated: "remove head and hands, remove ID marks like tattoos." A "Things to Remember" section contained alleged lessons learned: "Hit harder... light rope broke under stress."Jessica Taylor's remains were found along Ocean Parkway with her head removed and tattoos mutilated. The document allegedly describes exactly that methodology.When Suffolk County investigators returned to Rex Heuermann's home, they found infrared evidence of adhesive residue and push pins in the drop ceiling—exactly as allegedly described in the planning document.DA Ray Tierney stated: "The exact method by which these murders were committed in excruciating detail in that document is in some cases identical to the methodology used to murder the victims."Now the family that lived under the same roof for twenty-seven years has split. His wife Asa Ellerup still calls Rex her "hero" and refers to him as "my husband" despite their divorce. Their daughter Victoria reached a different conclusion: "most likely" guilty. She spoke with BTK's daughter about what it means to have an alleged serial killer for a father.According to prosecutors, female hairs found on multiple victims were allegedly consistent with DNA from both women. Neither is accused of involvement—the transfer allegedly came from Rex's clothing or their home.The daughter saw what the wife cannot.Rex Heuermann has pleaded not guilty. Trial is September 2026.Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1Instagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodThis publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.#RexHeuermann #LISK #GilgoBeachKiller #LongIslandSerialKiller #HK2002Document #GilgoBeachMurders #AsaEllerup #VictoriaHeuermann #SuffolkCounty #HiddenKillersPod

Someone tried to delete this file from Rex Heuermann's hard drives. Forensic analysts recovered it anyway. Tonight we're breaking down every section of what prosecutors call the Long Island Serial Killer's planning document for murder.The document was titled HK2002-04. Hidden on one of fifty-eight hard drives seized from the Massapequa Park basement. According to court documents, it allegedly contained eighty-seven details matching the methodology used on the Gilgo Beach victims.A "Supplies" section allegedly listed cutting tools, acid, tarps, and cat litter. A "Body Prep" section allegedly stated: "remove head and hands, remove ID marks like tattoos." A "Things to Remember" section allegedly contained lessons learned: "Hit harder... light rope broke under stress." References to specific pages in FBI profiler John Douglas's Mindhunter.Jessica Taylor's remains were found along Ocean Parkway with her head removed and tattoos mutilated. The document allegedly describes exactly that.When investigators returned to Rex Heuermann's home, they found infrared evidence of adhesive residue and push pins in the drop ceiling—exactly as allegedly described in the planning document.Now the family that lived with Rex for twenty-seven years is completely fractured. His wife Asa Ellerup still calls him her "hero." Described visiting him in jail as feeling like "a first date." Their daughter Victoria reached a different conclusion after speaking with BTK's daughter: "most likely" guilty.According to prosecutors, female hairs on multiple victims were allegedly consistent with DNA from both women. Neither is accused of involvement—prosecutors say the hair was likely transferred from clothing or the home.Both are victims. Just not of the same truth.Rex Heuermann has pleaded not guilty. Trial is September 2026.Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1Instagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodThis publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.#RexHeuermannLive #GilgoBeachKiller #LISK #LongIslandSerialKiller #MurderBlueprint #GilgoBeachMurders #AsaEllerup #VictoriaHeuermann #LISKTrial #HiddenKillersLive

Someone tried to delete this file. Forensic analysts recovered it anyway. According to prosecutors, document HK2002-04 is the Long Island Serial Killer's literal how-to guide for murder.The file was hidden on one of fifty-eight hard drives seized from Rex Heuermann's Massapequa Park basement. Created in 2000, modified through 2002, it allegedly contained eighty-seven details prosecutors say match the methodology used on the Gilgo Beach victims.According to court documents: A "Supplies" section allegedly listed cutting tools, acid, tarps, and cat litter. A "Body Prep" section allegedly stated: "remove head and hands, remove ID marks like tattoos." A "Things to Remember" section allegedly contained lessons learned: "Hit harder... light rope broke under stress." References to specific pages in FBI profiler John Douglas's Mindhunter appeared throughout.Jessica Taylor's remains were found along Ocean Parkway with her head removed and tattoos mutilated—allegedly matching the document exactly. When investigators returned to Rex Heuermann's home with infrared equipment, they found adhesive residue and push pin evidence in the drop ceiling—exactly as allegedly described.DA Ray Tierney: "The exact method by which these murders were committed in excruciating detail in that document is in some cases identical to the methodology used to murder the victims."The family that lived with Rex for twenty-seven years has fractured completely. Wife Asa Ellerup still calls him her "hero" and describes jail visits like "a first date." Daughter Victoria reached a different conclusion after speaking with BTK's daughter: "most likely" guilty.According to prosecutors, female hairs on multiple victims were allegedly consistent with DNA from both women. Neither is accused—prosecutors say the hair transferred from clothing or the home. Women linked to murder victims they never knew existed.The daughter saw what the wife cannot. Both are victims. Just not of the same truth.Rex Heuermann has pleaded not guilty. Trial is September 2026.Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1Instagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodThis publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.#RexHeuermann #GilgoBeachKiller #LISK #LongIslandSerialKiller #HK2002Document #GilgoBeachMurders #AsaEllerup #VictoriaHeuermann #MurderBlueprint #RexHeuermannTrial

If you have chronic hives and antihistamines aren't helping, there's a new treatment option to know about. In this episode of The Itch Review, we spotlight "Remibrutinib in Chronic Spontaneous Urticaria" published in The New England Journal of Medicine, March 2025. This article looks at the REMIX trials, which tested whether remibrutinib, a BTK inhibitor, can help adults whose chronic spontaneous urticaria (CSU) is not controlled by antihistamines alone. Remibrutinib works differently from antihistamines. Instead of blocking histamine after it's released, it stops mast cells from releasing those itch-causing chemicals in the first place. The FDA approved remibrutinib in September 2025.  What we cover in our episode about the REMIX trial: Understanding CSU: Chronic spontaneous urticaria causes itchy hives and swelling for more than 6 weeks with no clear trigger, and antihistamines don't work for everyone. How remibrutinib works: This BTK inhibitor stops mast cells from releasing chemicals like histamine, rather than blocking histamine after it's already released. Why do two identical trials: Running the same study twice (REMIX-1 and REMIX-2) with different patients helps prove the results are real, not a fluke. Key results: About half of patients reached well-controlled disease, and about 1 in 3 became completely clear of hives and itch. Safety and side effects: Petechiae (tiny dots of bleeding under the skin) were the main thing to watch for, but most cases were mild and went away on their own. DOWNLOAD THE INFOGRAPHIC More resources about chronic hives Chronic Spontaneous Urticaria - Allergy & Asthma Network Chronic Urticaria Toolkit What are hives? All episodes on urticaria *********** The Itch Review, hosted by Dr. Gupta, Kortney, and Dr. Blaiss, explores allergy and immunology studies, breaking down complex research in conversations accessible to clinicians, patients, and caregivers. Each episode provides key insights from journal articles and includes a one-page infographic in the show notes for easy reference. *********** Made in partnership with The Allergy & Asthma Network. Thanks to Novartis for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

The Long Island Serial Killer's family is split. The trial is coming. And both women may be victims of the same alleged lie.In today's episode, we examine the Gilgo Beach Killer family fracture—why his ex-wife Asa Ellerup still calls Rex her "hero" while daughter Victoria has publicly stated she believes he's "most likely" guilty of the Long Island murders.According to the Peacock documentary, Asa described Rex as her "savior" from a difficult first marriage. She said visiting him in jail felt like "a first date." Their divorce was finalized in March 2025—but she still refers to him as "my husband."Victoria's evolution was different. She acknowledged there were places in the Massapequa Park house she wasn't allowed as a child. She spoke with BTK's daughter about living in the aftermath. By the documentary's release, she'd reached her conclusion about LISK.But here's what makes the Gilgo Beach case even more disturbing. According to court documents, female hairs found on multiple victims' remains along Ocean Parkway were allegedly consistent with DNA from Asa and Victoria. Neither woman is accused of involvement. Suffolk County prosecutors say the hair was transferred from Rex's clothing.The women in the alleged Long Island Serial Killer's life were allegedly connected to murder victims they never knew existed. Their hair allegedly helped build the prosecution's case.The family unknowingly provided the evidence.They'll all be in the same courtroom in September 2026—one believing innocent, one believing guilty.Both are collateral damage in the Gilgo Beach case.Part 3 of 5.Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1Instagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodThis publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.#RexHeuermann #GilgoBeachKiller #LISK #TrueCrimeToday #LongIslandSerialKiller #AsaEllerup #VictoriaHeuermann #GilgoBeachMurders #OceanParkway #SuffolkCounty

What happens when you've loved a monster? When the evidence piles up but your memory tells you something different about the Gilgo Beach Killer?In Part 3 of our LISK series, we examine the fracture inside the alleged Long Island Serial Killer's family. His ex-wife Asa Ellerup still calls him her "hero." Their daughter Victoria says he's "most likely" the Gilgo Beach serial killer.Same house. Same twenty-seven years. Two completely different realities.According to court documents, every Gilgo Beach murder Heuermann is charged with allegedly occurred when his family was out of town. But the connection runs deeper. Female hairs found on victims' remains along Ocean Parkway were allegedly consistent with DNA from Asa and Victoria. Neither is accused of involvement—Suffolk County prosecutors say the hair was transferred.The women in the alleged LISK's life were allegedly linked to murder victims without knowing.Asa's attorney has suggested trauma bonding. In the documentary, she called Rex her "savior" from a difficult first marriage. Said visiting him in jail felt like "a first date."Victoria's path was different. She acknowledged places in the Massapequa Park house she wasn't allowed. Admitted her father missed family vacations during windows when murders allegedly occurred. By the documentary's release, she'd reached her conclusion about the Long Island murders.The daughter saw. The wife cannot.BTK's daughter Kerri Rawson offered support: "Asa and her kids are also victims."The Gilgo Beach trial is September 2026. Part 3 of 5.Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1Instagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodThis publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.#RexHeuermann #LISK #GilgoBeachKiller #HiddenKillers #LongIslandSerialKiller #AsaEllerup #VictoriaHeuermann #GilgoBeachMurders #OceanParkway #SuffolkCounty

Episode 91 - This two part series will focus on the horrific crimes of serial killer Dennis Rader, also known as BTK.

Part 3 of 5: The family fracture that defines the Long Island Serial Killer case.Asa Ellerup was married to Rex Heuermann for nearly three decades. In the Peacock documentary, she called him her "hero" and said Suffolk County police have "the wrong man." Their daughter Victoria has reached the opposite conclusion—telling producers she believes her father is "most likely the Gilgo Beach serial killer."Same house. Same twenty-seven years. Two completely different realities about LISK.In this episode, we examine what the alleged Gilgo Beach Killer's family saw and missed, why mother and daughter diverged, and what prosecutors say may have connected them to the alleged crimes without their knowledge.According to court documents, every murder Heuermann is charged with allegedly occurred when his family was out of town. Wife in Iceland, Maryland, New Jersey—each absence allegedly corresponded with a victim's disappearance along Ocean Parkway.But the connection runs deeper. Female hairs found on multiple victims' remains were allegedly consistent with DNA from Asa and Victoria. Neither is accused of involvement. Prosecutors say the hair was transferred from Rex's clothing.The women in the alleged Long Island Serial Killer's life were allegedly linked to murder victims without knowing.Victoria spoke with Kerri Rawson, BTK's daughter, about what it means to have an alleged killer for a father. By the documentary's release, she'd reached her conclusion about the Gilgo Beach murders.Asa still plans to attend every day of the LISK trial. Still calls Rex her husband.The trial is September 2026. Both will be in that courtroom—one believing innocent, one believing guilty.Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1Instagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodThis publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.#RexHeuermann #GilgoBeach #LISK #GilgoBeachKiller #LongIslandSerialKiller #AsaEllerup #VictoriaHeuermann #GilgoBeachMurders #OceanParkway #SuffolkCounty

The family is split. The trial is coming. And the question remains: How did Rex Heuermann allegedly hide as LISK for thirty years?Today we break down the psychology of compartmentalization and what it reveals about the man prosecutors call the Gilgo Beach Killer. Rex Heuermann is charged with seven Long Island murders spanning 1993 to 2010. He's pleaded not guilty and maintains his innocence.But what makes this case different is the family fracture. His ex-wife Asa Ellerup still calls him her "hero." She told Peacock documentary filmmakers: "I know what bad men are capable of doing. Not my husband. You have the wrong man."Their daughter Victoria sees it differently. According to producers, she now believes her father is "most likely the Gilgo Beach serial killer."How does the same man produce two opposite conclusions from the people who knew him best?According to forensic psychologist Scott Bonn, serial killers have "the ability to flip a switch and go from family man to sadistic killer." Dennis Rader, BTK, was a church council president. Gary Ridgway held a steady job for thirty-two years.Prosecutors allege LISK took it further. Every murder allegedly occurred when his family was out of town. Cell phone records allegedly place him with burner phones used to contact the Gilgo Four victims in every instance.Former FBI agent Robin Dreeke suggests predators often select partners who won't ask questions. If true, Asa wasn't foolish. She may have been chosen.The LISK trial begins September 2026. This is Part 1 of five.Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1Instagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodThis publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.#RexHeuermann #GilgoBeachKiller #LISK #TrueCrimeToday #LongIslandSerialKiller #GilgoBeachMurders #GilgoFour #OceanParkway #SuffolkCounty #LongIslandMurders

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of significant advancements and ongoing challenges that are reshaping the landscape of these dynamic industries.A key highlight in recent developments comes from Ascendis Pharma, which has secured FDA approval for Yuviwel, a treatment targeting achondroplasia, a genetic disorder leading to dwarfism. This approval underscores the potential of Ascendis' "transient conjugation" drug delivery platform, marking its third rare disease drug approval in just six years. The platform's ability to extend drug half-life and improve dosing frequency highlights its promise in addressing unmet medical needs in rare diseases, offering new hope for patients who previously had limited treatment options.In oncology, Merck's LITESPARC clinical trial program is showing promising results with Welireg (belzutifan) for clear cell renal cell carcinoma. The trials suggest that combination therapies involving Welireg could set a new standard of care. However, transitioning these regimens into universal standards remains challenging due to competitive dynamics and hurdles in clinical adoption.Shifting to cardiovascular health, United Therapeutics has made notable progress with its phase 3 trial success for a once-daily drug candidate for pulmonary arterial hypertension. The trial reported a 55% reduction in clinical worsening risk, positioning United Therapeutics to seek FDA approval and potentially challenge existing treatments from major players like Johnson & Johnson.Regulatory challenges are also evident. UniQure recently faced a setback when the FDA rejected its data package for AMT-130, a gene therapy for Huntington's disease. This rejection reflects the stringent regulatory environment surrounding gene therapies and emphasizes the need for robust data to meet approval criteria.On the technological front, Eli Lilly is making a strategic shift by collaborating with Nvidia to integrate advanced computing capabilities into drug development. By leveraging Nvidia's AI-driven supercomputing power, Lilly aims to accelerate drug discovery processes and enhance precision medicine approaches, potentially transforming traditional pharmaceutical lifecycles.Operational shifts are also occurring as Merck winds down Gardasil production at its North Carolina plant due to declining global demand. This decision reflects broader vaccination trends and may signal shifts in manufacturing strategies to align more closely with market demands.Leadership changes at Bavarian Nordic, following a failed private equity takeover bid, indicate potential strategic realignments within the company. The planned departure of CEO Paul Chaplin after 12 years could herald new directions and priorities.In logistics, Frontier Scientific Solutions is pioneering advancements in temperature-controlled supply chains—crucial for maintaining drug efficacy during distribution. Their innovative approaches are reshaping pharmaceutical logistics, ensuring reliable delivery systems worldwide.Meanwhile, Walgreens is venturing into digital health with a virtual weight management clinic offering access to GLP-1 medications. This move positions Walgreens within the competitive telehealth market as it responds to growing consumer demand for convenient healthcare solutions.These developments collectively reflect an industry in flux—balancing scientific innovation with regulatory rigor and strategic realignments. As companies navigate these challenges, the implications for patient care are profound, promising potential improvements in treatment efficacy and accessibility.Turning our attention to Roche, another successful Phase 3 trial for fenebrutinib—a BTK inhibitor targeting relapsing multiple sclerosis—has been reported. The study achieved its primary endpoint but raiseSupport the show

Part 1 of 5: How did Rex Heuermann—the man prosecutors call LISK—allegedly hide in plain sight for thirty years?This is the beginning of our comprehensive series examining the case against Rex Heuermann, the Manhattan architect charged with the Gilgo Beach murders. Seven victims between 1993 and 2010. Remains discovered along Ocean Parkway starting in December 2010. He's pleaded not guilty to all charges. His trial is set for September 2026.In this episode, we examine the psychology of compartmentalization—the phenomenon that allegedly allowed the Long Island Serial Killer to live as a family man while prosecutors say he was hunting victims whenever his wife and children were out of town.His ex-wife Asa Ellerup still calls him her "hero." In the Peacock documentary, she said: "I know what bad men are capable of doing. Not my husband. You have the wrong man."Their daughter Victoria has reached a different conclusion. According to documentary producers, she now believes her father is "most likely the Gilgo Beach serial killer."Forensic psychologist Scott Bonn explains that killers like BTK and the Green River Killer had "the ability to flip a switch and go from family man to sadistic killer." Former FBI agent Robin Dreeke suggests predators often select partners for traits that make them less likely to investigate red flags.According to Suffolk County prosecutors, every murder the alleged Gilgo Beach Killer is charged with occurred during windows when his family was traveling. Wife in Iceland, Maryland, New Jersey, Virginia—each absence allegedly corresponded with a victim's disappearance.Same house. Same twenty-seven years. Two completely different conclusions about who LISK really is.The mask, if prosecutors are right, didn't slip for three decades.Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1Instagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodThis publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.#RexHeuermann #GilgoBeach #GilgoBeachKiller #LISK #LongIslandSerialKiller #GilgoBeachMurders #OceanParkway #SuffolkCounty #MassapequaPark #GilgoFour

Drs. Wierda and O'Brien discuss emerging data showing the non-covalent BTK inhibitor pirtobrutinib outperforming traditional chemoimmunotherapy and showing favorable efficacy and safety versus ibrutinib in CLL. They also highlight promising early results from a triplet regimen for Richter transformation, suggesting the best survival outcomes yet seen in this historically high‑risk, hard‑to-treat population.

Neurologic complications of hematologic disorders are frequently encountered in clinical practice and can involve both the central and peripheral nervous systems. Early recognition and appropriate management in collaboration with a hematologist are essential to reduce morbidity and mortality. In this episode, Kait Nevel, MD, speaks with Lauren Patrick, MD, and Mark Terrelonge, MD, MPH, authors of the article "Neurologic Complications of Hematologic Disorders" in the Continuum® February 2026 Neurology of Systemic Disease issue. Dr. Nevel is a Continuum® Audio interviewer and a neurologist and neuro-oncologist at Indiana University School of Medicine in Indianapolis, Indiana. Dr. Patrick is an assistant professor of neurology at the University of California, San Francisco, in San Francisco, California. Dr. Terrelonge is an associate professor of neurology at the University of California, San Francisco, in San Francisco, California. Additional Resources Read the article: Neurologic Complications of Hematologic Disorders Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @IUneurodocmom Full episode transcript available here Dr Nevel: Thick blood, thin blood. These are terms often used by patients and caregivers to describe some of the hematologic disorders that can lead to neurological diseases such as stroke. So, when should we consider a hematologic disorder as a potential cause for neurological conditions, such as stroke or neuropathy. Today I have the opportunity to interview Drs Lauren Patrick and Mark Terrelonge to learn more about neurologic complications of hematologic disorders in their recent article in Continuum. Dr Jones: This is Dr Lyell Jones, editor-in-chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Nevel: Hello, this is Dr Kate Nevel. Today I'm interviewing Drs Lauren Patrick and Mark Terrelonge about their article on neurologic complications of hematologic disorders. This article appears in the February 2026 Continuum issue on neurology of systemic disease. Welcome to the podcast, and please introduce yourself to the audience. Dr Patrick: Thank you for having us. We're both thrilled to be here. I'm Lauren Patrick, a vascular neurologist and assistant professor at the University of California, San Francisco, and program director for the Vascular Neurology Fellowship here. Dr Terrelonge: And I'm Mark Terrelonge, I'm an associate professor of neurology and neuromuscular medicine here at UCSF and one of the associate program directors for the adult neurology residency. Nice to meet you. Dr Nevel: Nice to meet you both. Really looking forward to getting into your article and learning more. So, to kind of kick us off, I always like to ask what do you think is the most important takeaway from your article for the practicing neurologist? And maybe since there are two of you and I suspect you covered slightly different aspects of this article, maybe you could give us two most important takeaways. Dr Patrick: Sure. I think the biggest takeaway is to keep hematologic disorders on the differential when evaluating patients with neurologic symptoms. Conditions like sickle cell disease, myeloproliferative neoplasms, or plasma cell dyscrasias and paraproteinemia can cause strokes or peripheral neuropathies, and many have specific and targetable treatments. The early recognition and collaboration with our hematology colleagues can truly change patient outcomes, whether that's by initiating cytoreductive therapy, managing thrombocytopenia, or optimizing antithrombotic therapy. Dr Nevel: Great. So, this is a really big and diverse topic. As always, I'm going to urge our listeners to read the article because there is a lot of really good stuff in your article that we just don't have time to get into during this interview today. But you cover a lot of different hematological disorders and how they can cause neurological complications. One of the major neurological complications of hematological disorders is cerebral vascular events. So, I'm hoping, Warren, that you can walk us through a little bit. When should we consider workup of potential hematologic disorder as a cause when we see a patient with ischemic stroke, because certainly not all patients with ischemic stroke should be getting a broad hematological disorder work up. So how can we kind of identify early on that there might be something else at play? Dr Patrick: Absolutely, great question. So, in many cases, the underlying hematologic disorder is already known, such as sickle cell disease or polycythemia vera. But sometimes stroke is the initial presentation or manifestation of the disease. So red flags can include young age, recurrent cryptogenic strokes or thrombosis, and unusual locations like the cerebral venous system. Laboratory clues such as unexplained erythrocytosis, thrombocytosis, thrombocytopenia, or hemolytic anemia should raise suspicion for an occult hematologic disorder. In the setting of acute illness, immune-mediated or heparin-induced thrombocytopenia or thrombotic microangiopathies should be suspected in patients that have hemorrhagic and or thrombotic complications, particularly when relevant lab disturbances are present. Acquired thrombophilia such as anti-phospholipid antibody syndrome should be considered in young patients with autoimmune disease, prior venous or arterial thrombotic complications, or pregnancy morbidity. Now, these are rare causes overall, but they're important to catch because the management can differ dramatically from our typical stroke care. Dr Nevel: Great. And what are some of the most common inherited or acquired thrombophilias and when should we be sending these labs? Dr Patrick: The hematologic causes really account for small minority of arterial strokes approximately one to two percent, but among those, sickle cell disease, anti-phospholipid antibody syndrome and the myeloproliferative neoplasms are the most common. Timing of testing is key. So, the genetic thrombophilia panels can be drawn at presentation, but lab values such as protein C, protein S, and antithrombin levels may be falsely low during acute thrombosis, so they're often repeated weeks later. Similarly, for anti-phospholipid antibody testing that should be done at presentation and when positive, confirmed at twelve weeks, since transient positivity can occur with affections or acute events. So, in patients that are already anticoagulated for anti-phospholipid antibody syndrome, testing becomes particularly tricky, especially with lupus anticoagulant assays. Some results need to be interpreted carefully or repeated when feasible. The main message is to collaborate early with our hematology colleagues to guide the timing and interpretation of these studies. Dr Nevel: Yeah, wonderful. Thank you. I'll ask some similar questions about neuropathy. So when should we consider an underlying hematologic disorder as being the cause for someone's neuropathy? Dr Terrelonge: So, luckily for a neurologist, then serum protein electrophoresis or an SPEP is already a part of the first pass evaluation for even the most common neuropathies we see, technically already considered every time we do an evaluation. However, we do know that most neuropathies progress very slowly and don't really lead to significant limitations in patient activities of daily living. And for those, the initial workup step, you may not need to do any additional search for any hematologic diseases after that first step. Within patients who start to have more unusual features with their neuropathy, including a rapid progression, early proximal weakness, significant and extremely painful neuropathies, significant ataxia, or new tremor or anything that's kind of outside of the garden variety neuropathy, then you should start to think about a hematologic cause. Additionally, if a patient already has a known hematologic malignancy or process before their neuropathy, there should be some form of assessment to see through exam or electrodiagnostically if the two are correlated. I do have to add one caveat, though, and that's just because someone has a hematologic malignancy or a paraprotein seen in their blood, their neuropathy and the neurologic syndrome don't necessarily have to be causally related. So, we have to do some additional testing to determine if the patient's presentation of the paraprotein are actually linked. Dr Nevel: Can you walk us through a little bit how we determine if they're associated or just coincidental? Dr Terrelonge: Yeah. So, for some of the proteins, there's a specific phenotype that will come with the specific protein. For example, an anti MAG proteinopathies or MAG standing for a myelin associated glycoprotein, it usually leads to a distal sensor and motor polyneuropathy where the most distal portions of nerves are affected. So, in that case, people might notice that they have numbness and weakness in their toes and their fingers, and it doesn't follow that typical length dependent pattern. So, in that case, if you have the anti mag neuropathy and the electrodiagnostic signature of an anti mag neuropathy along with the symptoms, you're more likely to think that the two are related then if not. Dr Nevel: Great. Thank you. And I was hoping you could speak a little bit more about amyloidosis just because I think that that's one that can be really tricky to diagnose. And I see patients, you know, have sometimes more drawn out evaluations or see multiple providers before a diagnosis is reached. So, can you speak a little bit more to how we diagnose amyloidosis in relationship to neuropathy or other neurological conditions and when we should push for more invasive testing like a nerve biopsy? Dr Terrelonge: So, amyloidosis certainly is a tricky diagnosis. I've been tricked by it and I think most of my neuromuscular colleagues have probably been tricked by it at least once. It's a hard diagnosis to make is it usually requires a pretty high index of suspicion, and also requires a tissue diagnosis to cinch. There're some patients who will come in with a prior history of amyloidosis and they're a little bit easier to figure out if the neuropathy is related. Maybe it's started in their heart or their kidney first and then you can just see if the type of amyloid they have usually deposits in nerve, and that may be enough. But if there's any diagnostic uncertainty, you could go forward with tissue biopsy. But it's patients in which the neuropathy is the first symptom that amyloidosis can be especially tricky to diagnose. It's a primarily light chain disease. So, if you do only an SPEP as a part of your initial neuropathy evaluation, you could miss it. But usually, the patients will have either a severely painful neuropathy, early autonomic dysfunction, or really prominent bilateral carpal tunnel syndrome. So, if they have any of those, usually we'll add in an amyloid workup as a part of that of the rest of the workup, which would include both light chain evaluations to see if there's any increase in Lambda or Kappa light chains and then also biopsy. Biopsy can be of the skin or fat pad first, which have reasonable sensitivity for picking up disease, but they're not necessarily a hundred percent. So if the suspicion remains high in those cases, a nerve biopsy should be considered. And the reason why this is important is that the chemotherapeutic agents that we have now can actually help arrest a lot of these diseases and stop further organ involvement. So, if you think about it, it is important to keep pushing and looking until you find it. Dr Nevel: Thank you so much for that. And a follow up question to that, once patients are started on appropriate therapy, the diagnosis is made, chemotherapy is started, what's the typical clinical course that you see in terms of their neuropathy? Do you ever see improvement or is it arrest of worsening? Dr Terrelonge: Usually for amyloid, there is an arrest of disease, but in some patients, they could have some improvement, not necessarily a dramatic improvement, but some patients could see some reversal of symptoms. That may not necessarily be because nerves injured nerves are regrowing, but because of reorganization of nerves to muscle, they could have some strength increases or at least less pain. Dr Nevel: Yeah, thank you. So, when should we involve a hematologist in aiding in the evaluation of patients we suspect may have an underlying hematological disorder? You guys really outlined very nicely in your article some of the laboratory workup or other workup like you just talked about with amyloidosis. But at what point in that workup should we reach out to our hematology colleagues? Dr Patrick: I would say almost always. So, these disorders are inherently multi-system and benefit from early co-management. In acute sickle cell stroke, for example, hematology helps direct emergent exchange transfusion. For myeloproliferative disorders they guide cyto reduction and long term antithrombotic strategy. And for antibody mediated or plasma cell disorders, hematology determines disease specific therapies. So, neurology may help with identifying the presentation, but the definitive management is almost always shared with our hematology colleagues. Dr Nevel: And as you both have mentioned that a lot of times in these cases, their hematologic disorder may be already known before they present with their neurological symptoms. So, I imagine obviously in those cases that a hematologist hopefully is already heavily involved in their care. What do you think is the most difficult aspect of identifying and diagnosing patients with neurologic illness as having an underlying hematological disorder? Dr Patrick: The hardest part is maintaining a high index of suspicion, especially since hematologic causes account for a very small minority of arterial strokes. Most strokes are from traditional vascular risk factors like you mentioned, or cardio embolism, so it's easy to stop diagnostic evaluation after standard studies have been performed. An example of a challenging case is a patient that's young, they've had recurrent cryptogenic stroke, and they could have antiphospholipid antibody syndrome, but it can be easy to miss if their antibody titers are borderline or if they're already anticoagulated, which would complicate retesting. So, it's about balancing the urge to over-test with recognizing the few cases where identifying A hematologic cause truly changes that management. Dr Terrelonge: And then on the neuropathy side, probably the hardest part is deciding what's causal and what's coincidence. Monoclonal gammopathy of unknown significance, or MGUS, is really common in older adults, so not every M-spike on an SPEP explains a neuropathy. And even sometimes there's times when the neurologic picture will develop a little bit faster than the hematologic one. So, it's hard to put the two together. Dr Nevel: Yeah. What's the most rewarding aspect of taking care of patients with complications from their hematologic disorders? Dr Patrick: It's deeply rewarding when a targeted diagnosis leads to a tangible improvement in that patient's care. For example, identifying A cryptogenic stroke is being due to myeloproliferative neoplasm or an inherited thrombophilia allows us to move from empiric treatment to possible disease specific strategy. It's really gratifying to give patients that clarity, to give them a diagnosis and in some cases prevent future events. Dr Terrelonge: Agreed. And even on the neuropathy side, almost all of the neuropathies that are hematologically related are treatable. So, it's so satisfying whenever you have a patient with say an anti-MAG neuropathy or Waldenström can start the patient on therapy, and you can see someone who's been having a progressive decline to stability and in those cases sometimes even significant recovery. Dr Nevel: Yeah, absolutely. Very rewarding when you can identify the problem and make it better. That's what it's all about. So, what are the future areas of research in this area? What do we still need to learn? Dr Patrick: There's still a lot to learn. I think we need better data on the safety of acute reperfusion therapy and antithrombotic agents, particularly in patients that are at dual risk for bleeding and thrombosis. Other examples, secondary prevention strategies and anti-phospholipid antibody syndrome. What's the best target INR? Do you add aspirin to warfarin or not? All of that is often left up to expert opinion. What's the best management for adults with sickle cell stroke? There are many open questions there. A lot of the protocols that we have in place for sickle cell patients that are adults as derived from pediatric literature and there's vast potential in terms of disease modifying therapies, especially in the fields of sickle cell disease and amyloidosis. And we'll need to reassess how those treatments may change neurologic outcomes. Dr Terrelonge: I think on the neuropathy side that having some form of new biomarkers to help us clearly know of the neuropathy and that hematologic illness are associated would be very helpful. On the treatment side, a lot of this is really being driven by the hematology space, but new therapies that treat hematologic plasma cell disorders, including some of the new BTK inhibitor, may be incorporated relatively soon into the algorithm for how we treat many of our patients. I'm excited to see what's to come from this. Dr Nevel: Wonderful. Thank you so much for sharing your knowledge with us today. I know I've certainly learned a lot by reading your article and through our discussion today. Highly encourage our listeners to read your wonderful article, which is a very thorough review of hematologic disorders and neurological complications. Again, today I've been interviewing Dr Lauren Patrick and Dr Mark Terrelonge on their article Neurologic Complications of Hematologic Disorders, which appears in the February 2026 Continuum issue on Neurology of Systemic Disease. Please be sure to check out Continuum Audio episodes from this and other issues. And as always, thank you so much to our listeners for joining today, and thank you so much to Lauren and Mark. Dr Terrelonge: Yeah, thank you so much for having us. Dr Patrick: Thank you so much for having us and for highlighting this topic. We hope the issue encourages clinicians to think broadly about hematologic causes of neurologic disease and to continue collaborating closely with our hematology colleagues. It's a complex but very fascinating intersection for both of our fields. Dr Monteith: This is Dr Teshamae Monteith, associate editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in depth and clinically relevant information important for neurology practitioners. Use this link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/AudioCME. Thank you for listening to Continuum Audio.

What happens when you strap Ted Bundy, Jeffrey Dahmer, Richard Ramirez, BTK, Golden State Killer—and O.J. Simpson—to an FBI polygraph? Former FBI Polygraph Division Chief Kendall Shull (world's only Master's in Polygraphy) reveals the shocking truth: psychopaths think they can ice-cold it, but the body betrays them. O.J. failed multiple defense tests (one scored "definite deception"), Dahmer passed early due to zero remorse, but most guilty killers crack under real questioning. Host Tom Zenner & Kato Kaelin dive deep with insider stories from decades in FBI interrogations—rapport tricks, countermeasures that DON'T work, why innocents sometimes fail, and high-stakes cases like spies & terrorists.If you love true crime, FBI secrets, O.J. trial breakdowns, lie detector exposés, or serial killer psychology, smash play—this episode changes everything! Subscribe to Tom Zenner Scandal for more scandalous deep dives!

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into the dynamic landscape of these industries, exploring significant regulatory shifts, scientific breakthroughs, and strategic corporate maneuvers that are shaping the future of healthcare.The pharmaceutical and biotech sectors are currently navigating a period of profound transition. Recent regulatory developments have captured attention, particularly the U.S. Supreme Court's decision to overturn emergency tariffs imposed by the previous administration. This ruling is pivotal as it alleviates financial pressures on the industry, allowing companies to redirect their resources towards innovation and development. It underscores the interconnectedness of global supply chains and highlights the importance of stable regulatory environments for fostering industry growth.In a notable advancement within oncology, AstraZeneca has achieved FDA approval for its combination therapy of Calquence and Venclexta as an all-oral regimen for first-line chronic lymphocytic leukemia (CLL). This approval not only positions AstraZeneca competitively in the BTK inhibitor market but also signifies a shift towards more patient-friendly treatment regimens. By simplifying therapy, this development promises to enhance patient compliance and improve outcomes, challenging existing standards in CLL care.Meanwhile, internal challenges at the Centers for Disease Control and Prevention have led to a postponement of a critical vaccine advisory panel meeting. This delay occurs amid evolving vaccine policies that have sparked debate within the public health community, potentially impacting immunization strategies and initiatives aimed at bolstering public health.Corporate governance within the industry is also experiencing shifts. Novo Nordisk has nominated two industry veterans to its board as part of an ongoing strategy to align leadership with evolving business objectives. Similarly, Roche is contemplating divesting its once-blockbuster antibiotic Rocephin in response to competitive pressures from generics in Europe. These moves reflect a broader industry trend where companies are re-evaluating their portfolios to better respond to market dynamics and patent expirations.Novartis is making strategic changes as well by selling its stake in Novartis India Limited while maintaining separate commercial and R&D interests in the region. This action highlights a growing trend among pharmaceutical giants towards streamlining operations and focusing on high-growth areas—a strategy aimed at maximizing resource allocation efficiency.Despite narrowly missing a $1 billion revenue target for 2025, Madrigal Pharmaceuticals remains optimistic about the growth prospects of its drug Rezdiifra within the metabolic dysfunction-associated steatohepatitis (MASH) market. The company anticipates further expansion driven by unmet medical needs, underscoring the competitive dynamics within this therapeutic area.In personnel movements that could influence strategic directions, Daiichi Sankyo has appointed former Novartis CMO John Tsai as head of its R&D division. His expertise is expected to bolster Daiichi's focus on oncology and other critical therapeutic areas, potentially accelerating innovation within their drug development pipeline.Meanwhile, Manus Bio has secured a $15 million contract with the U.S. government for domestic supply of shikimic acid, an essential component for producing Tamiflu. This contract highlights efforts to strengthen domestic pharmaceutical supply chains amid global uncertainties—a crucial consideration for ensuring medication availability during crises.In clinical research, a setback was observed with Grail's Galleri cancer blood test trial failing to meet its primary endpoint in collaboration with the NHS. The resulting decline in GrailSupport the show

Today’s guest is Corey Mead. Although Corey is not from Wichita, he wrote a book called The Pursued that just came out based on the real-story of The Poet, a psychopath in Wichita back in the era of BTK. Get the book here: https://a.co/d/ilaXZfP The post Corey Mead – Author of The Pursued | Wichita Life Podcast #100 appeared first on Wichita Life.

Episode 90 - This two part series will focus on the horrific crimes of serial killer Dennis Rader, also known as BTK.

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a wide array of topics, from groundbreaking therapies and strategic corporate moves to regulatory shifts and industry trends shaping the future of healthcare.We begin with Eli Lilly, which is making significant strides with its combined Zepbound and Taltz therapy, showing promising results in the treatment of psoriasis and obesity. This combination therapy, initially successful in psoriatic arthritis, is set to transform treatment protocols by bridging gaps between psoriasis and obesity. This dual-targeting approach highlights a burgeoning trend in the industry: the use of combination therapies to enhance patient outcomes while streamlining treatment regimens. This strategy not only promises better management of interconnected conditions but also reflects a broader industry goal of maximizing therapeutic reach with existing drugs.Novartis is advancing its portfolio with the oral BTK inhibitor, Rhapsido, following a successful Phase 3 trial for a new chronic hives subtype. This development underscores Novartis's commitment to addressing niche markets and unmet medical needs, emphasizing the pharmaceutical industry's focus on expanding the utility of existing drugs. Additionally, Novartis has entered into a notable partnership with Macrocycle Biotech for cardiovascular drug development. This collaboration represents a broader trend where large pharmaceutical companies seek innovative partnerships to expand their therapeutic portfolios through cutting-edge biotech solutions.Meanwhile, Moderna's influenza vaccine submission has been accepted by the FDA after an initial rejection, illustrating a responsive regulatory environment crucial for timely access to vaccines amid potential flu outbreaks.Johnson & Johnson's $1 billion investment plan in the U.S., focusing on cell therapy, aligns with broader industry trends towards personalized medicine and advanced therapeutic approaches. This investment is part of a strategic pivot towards cell and gene therapies that promise to redefine treatment pathways for complex diseases. Similarly, Bayer's $7.25 billion settlement over Roundup litigation shows an industry keen on resolving legal challenges swiftly to refocus efforts on innovation.Regulatory reforms are also gaining attention, with proposals aimed at streamlining FDA processes to enhance drug access and reduce burdens. These reforms could significantly impact drug development timelines and market entry strategies, reflecting an ongoing discourse on balancing regulation with fostering innovation.On a global scale, Stada's €85 million investment in Saudi Arabia points to a strategic move towards enhancing supply chain resilience in the Middle East and North Africa. This aligns with industry trends focusing on regional manufacturing capabilities to ensure drug availability while reducing logistical complexities.A notable example of strategic resource allocation is Eli Lilly's $100 million upfront payment for CSL's IL-6 antibody development rights. This reflects an adaptive approach where initial clinical setbacks are seen as opportunities for new therapeutic ventures rather than dead ends.Turning our attention to Alzheimer's research, Korsana Biosciences has emerged from stealth mode with substantial funding aimed at developing an anti-amyloid antibody capable of crossing the blood-brain barrier. This effort addresses a critical need within Alzheimer's disease treatment—a field marked by intense competition and scientific challenge. Parallelly, IQVIA Biotech highlights the importance of accelerating early-stage interventions for Alzheimer's through data analytics and optimized clinical trials. Such efforts aim to expedite regulatory approvals and bring new therapies to market faster—a trend indicative of leveragSupport the show

När gärningsmannaprofilering behövdes som mest och hade som bäst förutsättningar att lyckas var man inte ens i närheten av att lösa ett av de mest uppmärksammade seriemördarfallen. Seriemördaren BTK. Bind. Torture. Kill. Hur pålitlig är då gärningsmannaprofilen för Palmemordet? Avsnitt 477: https://poddtoppen.se/podcast/1086387447/palmemordet/477-palmemordskonferensen-2025-gunnar-wall-om-garningsmannaprofilerGunnars blogg: https://gunnarwall.wordpress.com/2024/09/Seriemördarpoddens serie om BTK: https://shows.acast.com/seriemordarpodden-1/episodes/btk-del-1Av och med Dan Hörning. Manus av Gunnar Wall.Sponsra Palmemordet på Patreon: https://www.patreon.com/palmemordetKontakta Palmemordet: zimwaypodcast@gmail.com Hosted on Acast. See acast.com/privacy for more information.

As new calcium-modifying technologies expand the repertoire of below-the-knee (BTK) arterial disease interventions, how should your treatment algorithm evolve, and what endpoints matter most? In this episode of the BackTable Podcast, Dr. Constantino Peña of the Baptist Health Miami Cardiac and Vascular Institute joins Dr. Sabeen Dhand to discuss the latest advancements in BTK chronic limb-threatening ischemia (CLTI) therapies and the push to improve on current vessel preparation outcomes. --- This podcast is supported by: Shockwave Medicalhttps://shockwavemedical.com/ --- SYNPOSIS The physicians discuss the evolution of tibial arterial therapies, the challenges presented by heavily calcified lesions, and the impact of new tools, particularly the Shockwave E8 intravascular lithotripsy (IVL) device, on procedural considerations and endpoints. Dr. Peña shares his treatment algorithms and offers practical advice on selecting the right tools for each unique case. The episode closes with speculation on the future of treatment options and technologies for BTK disease, and the growing need for robust data to guide patient-specific treatment. --- TIMESTAMPS 00:00 - Introduction02:11 - Understanding Tibial Disease and Treatment Evolution07:22 - Advancements in Tibial Disease Treatment and the Role of IVL15:31 - Techniques for Effective IVL Sizing and Usage 21:28 - Challenges and Innovations in Tibial Disease Management26:48 - Innovations in Stent Technology30:43 - Combining IVL with Adjunct Therapies32:13 - Addressing Misconceptions in Tibial Treatment37:54 - Advancements in Intravascular Lithotripsy40:59 - Future of Vascular Treatments43:42 - Final Thoughts

I avsnitt 477 talade Gunnar Wall på Palmemordskonferensen 2025 om Gärningsmannaprofilering. Det här är en mer djupgående granskning av Gärningsmannaprofilering i allmänhet och gärningsmannaprofilen för Palmemordet i synnerhet. I det här avsnittet går vi genom gärningsmannaprofilerings historia fram till och med det fallet där det fanns absolut bäst förutsättningar för gärningsmannaprofilering: Seriemördaren BTK. Bind. Torture. Kill. Avsnitt 477: https://poddtoppen.se/podcast/1086387447/palmemordet/477-palmemordskonferensen-2025-gunnar-wall-om-garningsmannaprofilerGunnars blogg: https://gunnarwall.wordpress.com/2024/09/Seriemördarpoddens serie om BTK: https://shows.acast.com/seriemordarpodden-1/episodes/btk-del-1Av och med Dan Hörning. Manus av Gunnar Wall.Sponsra Palmemordet på Patreon: https://www.patreon.com/palmemordetKontakta Palmemordet: zimwaypodcast@gmail.com Hosted on Acast. See acast.com/privacy for more information.

Drs. Coombs and Danilov explore how to optimally sequence covalent BTK inhibitors, non‑covalent BTK inhibitors (such as pirtobrutinib), and venetoclax-based regimens for relapsed CLL, emphasizing real-world data and emerging trial results. They highlight that treatment choices hinge on prior response depth and duration, tolerability, mutational profile, and the need to preserve future options and clinical trial eligibility.

The February 2026 recall features four previously posted episodes on multiple sclerosis. The episode begins with a conversation with Dr. Wallace J. Brownle discussing whether dissemination in time is essential to diagnois relapsing MS. The discussion continues with Dr. Daniel Ontaneda regarding the 2024 revisions of the McDonald criteria for diagnosing multiple sclerosis. The episode then transitions into a conversation with Dr. Jiwon Oh about BTK inhibitors and recent data on tolebrutinib in multiple sclerosis. The episode concludes with Dr. Sandra Vukusic addressing the differences in disease-modifying therapies for female versus male patients with multiple sclerosis.  Podcast link: Investigating Whether Dissemination in Time Is Essential to Diagnose Relapsing MS 2024 McDonald Criteria  BTK Inhibitors in Multiple Sclerosis Treatment Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis Podcast article: Investigating Whether Dissemination in Time Is Essential to Diagnose Relapsing Multiple Sclerosis  Diagnosis of Multiple Sclerosis: 2024 Revisions of the McDonald Criteria  Tolebrutinib versus Teriflunomide in Relapsing Multiple Sclerosis  Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis  Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis Disclosures can be found at Neurology.org. 

In today's episode, Andrew Lipsky, MD, reviewed recent updates with BTK inhibitors in the chronic lymphocytic leukemia (CLL) treatment paradigm, including the clinical significance of the December 2025 FDA approval of pirtobrutinib (Jaypirca) in relapsed/refractory CLL and its effect on sequencing decisions for this disease. Dr Lipsky is an assistant professor of medicine at the Columbia University Medical Center in New York, New York.In the exclusive interview, Dr Lipsky expanded on the positioning of this agent within the evolving CLL treatment paradigm and patient characteristics that may inform its use in practice; key efficacy and safety findings from a pooled analysis of the phase 3 BRUIN CLL-321 (NCT04666038) and phase 1/2 BRUIN LOXO-BTK-18001 (NCT03740529) studies presented during the 2025 ASH Annual Meeting; and the evolving role of BTK inhibitors as a whole in CLL management.

Based on the iconic, Emmy-nominated series on A&E, this show explores some of the most difficult-to-solve murders, which stymied investigators and went cold, sometimes for decades. In fact, one-third of all murders in America remain open. But thanks to dogged investigators and breakthroughs in forensic technology, these cases become part of the rare 1% of cold cases that are ever solved. In this episode, the story of the hunt for one of the most notorious serial killers in recent American history - the BTK killer, who terrorized the Wichita, Kansas, area for years. After committing at least seven brutal murders, BTK (for Bind, Torture, Kill) vanished for over 25 years before sending clues of his crimes to the media in 2004. He continued to avoid capture until a forensic computer expert traced a computer disc that led investigators to a surprising suspect - a church council president.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dr. Marilia Bernardes, Infectious Diseases Faculty at the Morsani College of Medicine in Tampa, FL, presents an overview of the immune system. Dr. Bernardes skillfully breaks down the immune system into 4 distinct pillars and then its individual biological components. She presents the “who,” “what” and “why” for neutrophils, B-cells, and T cells and covers cellular and humoral immune deficits. She also covers newer immunotherapies such as BTK inhibitors, CAR-T and bispecifics, as well as biologics and other small molecules. Some rapid-fire cases are also presented to integrate the listener’s understanding of the material presented.

The LAPD’s most famous cold case, the Black Dahlia, has haunted headlines for generations, and a renewed wave of speculation now argues she was killed by the same person who later called himself the Zodiac. In this episode of "Zone 7," Sheryl McCollum is joined by forensic pathologist Dr. Priya Banerjee and forensic psychologist Dr. Joni Johnston to put that theory to the test. They argue Elizabeth Short’s murder reads as intimate and rage-driven, marked by postmortem mutilation and staging, while the Zodiac attacks appear cold and more mission-oriented, closer to an execution than a personal assault. They also clarify the difference between modus operandi and psychological signature, explain why signatures do not just “cool off” over decades, and urge civilians and investigators alike to test assumptions, scrutinize claims, and bring in smarter minds when the facts demand it. Guest Bios: Dr. Priya Banerjee is a board-certified forensic pathologist with extensive experience in death investigation, clinical forensics, and courtroom testimony. A John’s Hopkins graduate, she served for over a decade as Rhode Island’s state medical examiner and now leads a private forensic pathology practice. Dr. Joni Johnston is a forensic psychologist, private investigator, and crime writer. Her work includes prison and parole settings, court-related forensic services, workplace misconduct investigations, parole evaluations for mentally disordered offenders, and expert testimony in criminal and civil cases. About the Host Sheryl “Mac” McCollum is an active crime scene investigator for a Metro Atlanta Police Department and the director of the Cold Case Investigative Research Institute, which partners with colleges and universities nationwide. With more than 4 decades of experience, she has worked on thousands of cold cases using her investigative system, The Last 24/361, which integrates evidence, media, and advanced forensic testing. Her work on high-profile cases, including the Boston Strangler, Natalie Holloway, Tupac Shakur and the Moore’s Ford Bridge lynching, led to her Emmy Award for "CSI: Atlanta" and induction into the National Law Enforcement Hall of Fame in 2023. Social Links: X: @149Zone7 Facebook: @sheryl.mccollum Instagram: @officialzone7podcast Email: coldcase2004@gmail.com Enjoying Zone 7? Leave a rating and review where you listen to podcasts. Your feedback helps others find the show and supports the mission to educate, engage, and inspire. Preorder Sheryl’s upcoming book, "Swans Don’t Swim in a Sewer: Lessons in Life, Justice, and Joy from a Forensic Scientist," releasing May 2026 from Simon and Schuster. Highlights: • (0:00) Sheryl McCollum frames the Black Dahlia and Zodiac question, and why “same killer” theories require disciplined testing • (1:15) The Zodiac’s moniker, symbols, and ciphers as behavioral evidence through public messaging • (2:45) Dr. Joni Johnston on why the Black Dahlia reads as personal, targeted violence rather than opportunistic killing • (4:15) Modus operandi versus signature behavior, and where true crime narratives often blur the line • (5:45) Antemortem versus postmortem behavior, and how that distinction changes scene interpretation • (7:00) Why signature tends to remain stable over time, even when method or opportunity shifts • (8:00) What autopsy findings and scene details can suggest about intent • (15:00) Facial carving as humiliation, defacement, and control, and what that suggests about motive • (18:15) Tattoo removal and insertion framed as symbolic degradation • (20:15) Escalation narratives and control needs, testing patterns against a “same offender” theory • (27:00) BTK comparison, and why taunting and offender messaging are not unique identifiers • (31:45) Timeline gaps and intent differences as evidence against a single-offender theory • (33:00) Closing quote and final takeaway on evidence, teamwork, and disciplined disagreement See omnystudio.com/listener for privacy information.

In this episode of the Oncology Brothers podcast, we were joined by Dr. Julie Vose, a leading expert in lymphoma from the University of Nebraska Medical Center. Together, we delved into the key abstracts presented at ASH 2025, focusing on significant studies in lymphoma and chronic lymphocytic leukemia (CLL). Episode Highlights: ● EPCORE FL-1: the approval of Epcoritamab in combination with Rituximab and lenalidomide for relapsed refractory follicular lymphoma ● CLL-17: comparison between continuous BTK inhibitors and fixed-duration venetoclax with obinutuzumab ● BRUIN CLL-313: insights into the non-covalent BTK inhibitor, pirtobrutinib, and its effectiveness in the frontline setting compared to traditional treatments ● S1826: a three-year update on the use of Nivolumab-AVD versus BV-AVD in advanced-stage Hodgkin's lymphoma, showcasing improved PFS and better tolerability Join us as we unpack these practice-changing studies and discuss their implications for community oncologists. Follow us on social media: •⁠  ⁠X/Twitter: https://twitter.com/oncbrothers •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers •⁠  Website: https://oncbrothers.com/ Don't forget to subscribe for more insights and highlights from oncology conferences! #ASH25 #Oncology #Hematology #Lymphoma #CLL #CancerResearch

In this encore episode, retired FBI agent and criminal profiler Candice DeLong explores the case of Dennis Rader, also known as BTK. Over 17 years, Rader tortured and murdered 10 people, while playing a game of cat and mouse with law enforcement and the media. Candice digs into how one of the most infamous killers in history, was able to mask himself as loving father, church group president, and a government worker until his arrest in 2005.Be the first to know about Wondery's newest podcasts, curated recommendations, and more! Sign up now at https://wondery.fm/wonderynewsletterNeed more Killer Psyche? With Wondery+, enjoy exclusive episodes, early access to new ones, and they're always ad-free. Start your free trial in the Wondery App or visit wondery.app.link/TI5l5KzpDLb now.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this chilling Hidden Killers deep dive, we confront two disturbing revelations about Bryan Kohberger — the kind that point to hidden behavior far beyond what happened on King Road. Retired FBI Behavioral Analysis Program Chief Robin Dreeke joins Tony Brueski to break down the unsettling possibility that Kohberger maintained secret stashes of weapons, stolen items, and trophies — and that investigators may have only scratched the surface. First, we explore the “hidey hole” theory: a private cache where Kohberger may have stored the missing KA-BAR knife, clothing, stolen items, or other evidence he didn't want to destroy. Dreeke draws direct parallels to BTK, Israel Keyes, and Robert Hansen — offenders who built entire systems of hidden drop sites to revisit, relive, and maintain control over their crimes. Kohberger's shovel with tested soil, his repeated trips to remote parks, and a long pattern of break-ins and petty theft suggest this behavior may have been developing for years. But the story gets darker. We also examine the two mystery ID cards found in Kohberger's possession — IDs belonging to women who were not his victims and who may not even know he ever had them. These weren't discovered in plain sight. They were tucked away, hidden in a glove box inside a box. Dreeke explains why offenders sometimes keep items like this: not as accidents, but as trophies, leverage, fantasies, or souvenirs of earlier intrusions. Why would a man who meticulously cleaned his car miss two IDs? He probably didn't. He simply didn't believe they were important to the crime he was trying to erase — a psychological compartmentalization common among escalating offenders. Together, these findings raise chilling questions:  • Did Kohberger have a cache?  • How many items were hidden?  • How many women were surveilled, targeted, or intruded upon?  • And how much evidence — or truth — is still buried? This is the behavioral blueprint investigators fear the most: escalation, souvenirs, and secrets carefully tucked away. #BryanKohberger #HiddenKillers #Idaho4 #FBIProfiler #EvidenceStash #TrophyBehavior #TrueCrimePodcast #CriminalPsychology #KnifeCache #RobinDreeke Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/@hiddenkillerspod Instagram https://www.instagram.com/hiddenkillerspod/ Facebook https://www.facebook.com/hiddenkillerspod/ Tik-Tok https://www.tiktok.com/@hiddenkillerspod X Twitter https://x.com/tonybpod Listen Ad-Free On Apple Podcasts Here: https://podcasts.apple.com/us/podcast/true-crime-today-premium-plus-ad-free-advance-episode/id1705422872

In this chilling Hidden Killers deep dive, we confront two disturbing revelations about Bryan Kohberger — the kind that point to hidden behavior far beyond what happened on King Road. Retired FBI Behavioral Analysis Program Chief Robin Dreeke joins Tony Brueski to break down the unsettling possibility that Kohberger maintained secret stashes of weapons, stolen items, and trophies — and that investigators may have only scratched the surface. First, we explore the “hidey hole” theory: a private cache where Kohberger may have stored the missing KA-BAR knife, clothing, stolen items, or other evidence he didn't want to destroy. Dreeke draws direct parallels to BTK, Israel Keyes, and Robert Hansen — offenders who built entire systems of hidden drop sites to revisit, relive, and maintain control over their crimes. Kohberger's shovel with tested soil, his repeated trips to remote parks, and a long pattern of break-ins and petty theft suggest this behavior may have been developing for years. But the story gets darker. We also examine the two mystery ID cards found in Kohberger's possession — IDs belonging to women who were not his victims and who may not even know he ever had them. These weren't discovered in plain sight. They were tucked away, hidden in a glove box inside a box. Dreeke explains why offenders sometimes keep items like this: not as accidents, but as trophies, leverage, fantasies, or souvenirs of earlier intrusions. Why would a man who meticulously cleaned his car miss two IDs? He probably didn't. He simply didn't believe they were important to the crime he was trying to erase — a psychological compartmentalization common among escalating offenders. Together, these findings raise chilling questions:  • Did Kohberger have a cache?  • How many items were hidden?  • How many women were surveilled, targeted, or intruded upon?  • And how much evidence — or truth — is still buried? This is the behavioral blueprint investigators fear the most: escalation, souvenirs, and secrets carefully tucked away. #BryanKohberger #HiddenKillers #Idaho4 #FBIProfiler #EvidenceStash #TrophyBehavior #TrueCrimePodcast #CriminalPsychology #KnifeCache #RobinDreeke Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/@hiddenkillerspod Instagram https://www.instagram.com/hiddenkillerspod/ Facebook https://www.facebook.com/hiddenkillerspod/ Tik-Tok https://www.tiktok.com/@hiddenkillerspod X Twitter https://x.com/tonybpod Listen Ad-Free On Apple Podcasts Here: https://podcasts.apple.com/us/podcast/true-crime-today-premium-plus-ad-free-advance-episode/id1705422872

This is a key segment from our definitive Hidden Killers with Tony Brueski coverage, focused on the true crime story that defined the year: Bryan Kohberger. We execute a full psychological autopsy on the criminology student who planned the impossible, revealing the "Perfect Crime" blueprint he crafted while simultaneously studying criminal minds. This cut revisits the most shocking evidence that proved his attack was not impulsive: The radical premeditation including the 20+ times he stalked the King Road house. The crucial timeline detail showing he acquired his K-Bar knife before even moving to Washington State. Most critically, we dive deep into the conflicting theories of the Silent Plea—the moment he admitted guilt but refused to give a reason. This episode explores the compelling idea that he chose this path to protect his parents from the trauma of testifying and potential public scrutiny, making it his final act of control. We also confront the darkest theories, including the possibility of a sexually motivated crime, drawing parallels between his alleged consumption of dark pornography and the victimology of monsters like Ted Bundy and BTK. This segment is essential viewing to understand the decade of quiet, dark obsession that led a criminology student to cross the line from academic study to real-world violence. It's the definitive analysis of the mind that thought it was smarter than the system.  #BryanKohberger, #IdahoMurders, #KohbergerMotive, #CriminologyStudentKiller, #TrueCrimeAnalysis, #PremeditatedMurder, #SilentPlea, #HiddenKillers, #TonyBrueski, #YearInReview Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/@hiddenkillerspod Instagram https://www.instagram.com/hiddenkillerspod/ Facebook https://www.facebook.com/hiddenkillerspod/ Tik-Tok https://www.tiktok.com/@hiddenkillerspod X Twitter https://x.com/tonybpod Listen Ad-Free On Apple Podcasts Here: https://podcasts.apple.com/us/podcast/true-crime-today-premium-plus-ad-free-advance-episode/id1705422872

This is a key segment from our definitive Hidden Killers with Tony Brueski coverage, focused on the true crime story that defined the year: Bryan Kohberger. We execute a full psychological autopsy on the criminology student who planned the impossible, revealing the "Perfect Crime" blueprint he crafted while simultaneously studying criminal minds. This cut revisits the most shocking evidence that proved his attack was not impulsive: The radical premeditation including the 20+ times he stalked the King Road house. The crucial timeline detail showing he acquired his K-Bar knife before even moving to Washington State. Most critically, we dive deep into the conflicting theories of the Silent Plea—the moment he admitted guilt but refused to give a reason. This episode explores the compelling idea that he chose this path to protect his parents from the trauma of testifying and potential public scrutiny, making it his final act of control. We also confront the darkest theories, including the possibility of a sexually motivated crime, drawing parallels between his alleged consumption of dark pornography and the victimology of monsters like Ted Bundy and BTK. This segment is essential viewing to understand the decade of quiet, dark obsession that led a criminology student to cross the line from academic study to real-world violence. It's the definitive analysis of the mind that thought it was smarter than the system.  #BryanKohberger, #IdahoMurders, #KohbergerMotive, #CriminologyStudentKiller, #TrueCrimeAnalysis, #PremeditatedMurder, #SilentPlea, #HiddenKillers, #TonyBrueski, #YearInReview Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/@hiddenkillerspod Instagram https://www.instagram.com/hiddenkillerspod/ Facebook https://www.facebook.com/hiddenkillerspod/ Tik-Tok https://www.tiktok.com/@hiddenkillerspod X Twitter https://x.com/tonybpod Listen Ad-Free On Apple Podcasts Here: https://podcasts.apple.com/us/podcast/true-crime-today-premium-plus-ad-free-advance-episode/id1705422872

How does a man live under the same roof as his wife and children while allegedly carrying out seven brutal murders over nearly three decades? In this powerful two-part breakdown, we bring together two of the nation's leading experts on human behavior—former FBI Special Agent Robin Dreeke and psychotherapist Shavaun Scott—to explain how Rex Heuermann may have maintained one of the most disturbing double lives in modern true crime. Robin Dreeke opens the episode with a deep dive into the psychology of compartmentalization, truth-default theory, and why spouses detect lies only about 50% of the time. He explains how Heuermann allegedly created a split existence: family man in Massapequa Park, predator operating in secrecy when his wife and children were out of town. Burner phones, controlled finances, rigid routines—each played into the illusion of normalcy. Dreeke draws critical parallels to notorious cases like BTK, revealing the subtle relationship red flags that can be missed even by those closest to the perpetrator. Then psychotherapist Shavaun Scott joins to analyze the chilling emotional dynamic captured in the Peacock documentary. Asa Ellerup's unwavering loyalty—even calling Rex her “hero”—opens a window into trauma bonding, coercive control, and the psychological grooming that can turn a spouse into an unknowing enabler. From Asa's isolation to tightly restricted access to finances and technology, Scott exposes the mechanisms that may have kept her locked inside Heuermann's constructed reality. Together, these insights reveal not just how a predator allegedly concealed his crimes, but how ordinary families can be pulled into extraordinary darkness without ever recognizing the danger. For anyone concerned about relationship safety, manipulation, or hidden abuse, this episode offers crucial perspective—and a sobering look at the human cost behind one of America's most haunting serial killer cases. #RexHeuermann #SerialKillerPsychology #GilgoBeachMurders #AsaEllerup #RobinDreeke #ShavaunScott #TrueCrimeAnalysis #DoubleLife #TraumaBonding #HiddenKillersPodcast Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/@hiddenkillerspod Instagram https://www.instagram.com/hiddenkillerspod/ Facebook https://www.facebook.com/hiddenkillerspod/ Tik-Tok https://www.tiktok.com/@hiddenkillerspod X Twitter https://x.com/tonybpod Listen Ad-Free On Apple Podcasts Here: https://podcasts.apple.com/us/podcast/true-crime-today-premium-plus-ad-free-advance-episode/id1705422872

How does a man live under the same roof as his wife and children while allegedly carrying out seven brutal murders over nearly three decades? In this powerful two-part breakdown, we bring together two of the nation's leading experts on human behavior—former FBI Special Agent Robin Dreeke and psychotherapist Shavaun Scott—to explain how Rex Heuermann may have maintained one of the most disturbing double lives in modern true crime. Robin Dreeke opens the episode with a deep dive into the psychology of compartmentalization, truth-default theory, and why spouses detect lies only about 50% of the time. He explains how Heuermann allegedly created a split existence: family man in Massapequa Park, predator operating in secrecy when his wife and children were out of town. Burner phones, controlled finances, rigid routines—each played into the illusion of normalcy. Dreeke draws critical parallels to notorious cases like BTK, revealing the subtle relationship red flags that can be missed even by those closest to the perpetrator. Then psychotherapist Shavaun Scott joins to analyze the chilling emotional dynamic captured in the Peacock documentary. Asa Ellerup's unwavering loyalty—even calling Rex her “hero”—opens a window into trauma bonding, coercive control, and the psychological grooming that can turn a spouse into an unknowing enabler. From Asa's isolation to tightly restricted access to finances and technology, Scott exposes the mechanisms that may have kept her locked inside Heuermann's constructed reality. Together, these insights reveal not just how a predator allegedly concealed his crimes, but how ordinary families can be pulled into extraordinary darkness without ever recognizing the danger. For anyone concerned about relationship safety, manipulation, or hidden abuse, this episode offers crucial perspective—and a sobering look at the human cost behind one of America's most haunting serial killer cases. #RexHeuermann #SerialKillerPsychology #GilgoBeachMurders #AsaEllerup #RobinDreeke #ShavaunScott #TrueCrimeAnalysis #DoubleLife #TraumaBonding #HiddenKillersPodcast Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/@hiddenkillerspod Instagram https://www.instagram.com/hiddenkillerspod/ Facebook https://www.facebook.com/hiddenkillerspod/ Tik-Tok https://www.tiktok.com/@hiddenkillerspod X Twitter https://x.com/tonybpod Listen Ad-Free On Apple Podcasts Here: https://podcasts.apple.com/us/podcast/true-crime-today-premium-plus-ad-free-advance-episode/id1705422872

Welcome back to our BTK/ASGBI Series! During this series, BTK fellow Agnes Premkumar and ASGBI hosts Jared Wohlgemut and Gita Lingam compare and contrast various aspects of surgery between the United States and the United Kingdom, debating who does what better.  We are happy to be continuing our AI discussion further with another episode. While last episode lay a foundation on discussing the unique differences in the role and regulation of AI in both these countries, now we delve into some of the clinical challenges. What does AI and the future of surgery look like in underserved locations such as the battlefield or the rural communities. What does this mean for our future as surgeons…will we be replaced? And how should we address the integration of AI within our practices?  We are thrilled to have our trio of experts discussing this further. Dr. Nelson is a surgical oncologist working at the Brook Army Medical Center in San Antonio, he's very interested in expanding the role of AI within surgical education and beyond. Dr. Larson is a general surgery resident at the Mayo Clinic. She's currently in her research time and finishing up her master's degree in AI and studying the role of machine learning within surgical practice. Dr. Mukherjee is a surgeon scientist alongside an Honorary Consultant General & Major Trauma Surgeon in Liverpool, England. His current research bridges academia with industry and is aimed at transforming the treatment of critical illness through the development of next-generation therapies for pancreatitis-induced acute lung injury through the utilisation of cutting-edge AI driven drug discovery approaches.  Take a listen and let us know what you think!  References: Johns' Hopkins Ex-Vivo Cholecystectomy by a Robot https://hub.jhu.edu/2025/07/09/robot-performs-first-realistic-surgery-without-human-help/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listen Behind the Knife Premium: General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-review Trauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlas Dominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkship Dominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotation Vascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-review Colorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-review Surgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-review Cardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-review Download our App: Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

Welcome back to our BTK/ASGBI Series! During this series, BTK fellow Agnes Premkumar and ASGBI hosts Jared Wohlgemut and Gita Lingam compare and contrast various aspects of surgery between the United States and the United Kingdom, debating who does what better.  In this episode, we delve into all things artificial intelligence (AI) within surgery. Both the US and the UK have unique approaches to managing AI within healthcare and our experts help break down these key similarities and differences. We will discuss what AI and machine learning means, what does regulation look like in both these regions, and how is AI being used in both these countries.  We are fortunate to have two representatives, Dr. Nelson and Dr. Larson, representing the US side. Dr. Nelson is a surgical oncologist working at the Brook Army Medical Center in San Antonio, he's very interested in expanding the role of AI within surgical education and beyond. Dr. Larson is a general surgery resident at the Mayo Clinic. She's currently in her research time and finishing up her master's degree in AI and studying the role of machine learning within surgical practice. We are fortunate to have Dr. Mukherjee representing the UK side. Dr. Mukherjee is a surgeon scientist alongside an Honorary Consultant General & Major Trauma Surgeon in Liverpool, England. He has a strong track record in research that spans the translational spectrum, with strengths in discovery science related to acute pancreatitis pathophysiology and mitochondrial injury, novel in vitro and in vivo experimental assay development and clinical translational research, including novel biomarker studies and clinical trials. He has won multiple awards, most recently the Hunterian Professorship 2024 from the Royal College of Surgeons of England. Take a listen and let us know what you think- what do you think is the best way to promote and regulate AI within healthcare?  Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listen Behind the Knife Premium: General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-review Trauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlas Dominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkship Dominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotation Vascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-review Colorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-review Surgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-review Cardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-review Download our App: Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

In 1974, Wichita, Kansas was shaken by a series of brutal attacks inside family homes. Men, women, and children were bound, tortured, and killed by a predator who called himself BTK. For 17 years, he terrorized the community, claiming at least 10 victims and taunting police with disturbing letters that detailed his crimes. Then in 1991, the killings abruptly stopped, leaving law enforcement and the public to wonder if the killer had vanished forever. For more than a decade, there was silence. Then in 2004, BTK resurfaced with new messages, reigniting fear in Wichita. But that renewed need for attention would ultimately be his downfall, and by the following year, detectives had identified the killer as Dennis Rader, a father of two, a Scout leader, and a trusted member of his church council. Rader was the last person anyone suspected of being a sexual sadist serial killer, but once investigators began putting all the puzzle pieces together, it became clear that Rader's family-man persona was just a mask covering the monster beneath. Try our coffee!! - www.CriminalCoffeeCo.com Become a Patreon member -- > https://www.patreon.com/CrimeWeekly Shop for your Crime Weekly gear here --> https://crimeweeklypodcast.com/shop Youtube: https://www.youtube.com/c/CrimeWeeklyPodcast Website: CrimeWeeklyPodcast.com Instagram: @CrimeWeeklyPod Twitter: @CrimeWeeklyPod Facebook: @CrimeWeeklyPod ADS: 1. https://www.HelloFresh.com/CrimeWeekly10FM - Get 10 FREE meals and FREE breakfast for LIFE! 2. https://www.Incogni.com/CrimeWeekly - Use code CRIMEWEEKLY for 60% off! 3. https://www.HelixSleep.com/CrimeWeekly - Get 27% off sitewide NOW! 4. https://www.EatIQBAR.com - Text WEEKLY to 64000 for 20% off ALL IQBAR products and FREE shipping! 5. https://www.Rula.com/CrimeWeekly - Make your mental health your top priority today with Rula! Let them know we sent you!

After killing Marine Hedge in 1985 and Vicki Wegerle in 1986, Dennis Rader vanished into suburban normalcy for almost twenty years—leading Cub Scouts, serving as church president, and installing home alarms for terrified neighbors. While the task force chased ghosts, he privately curated scrapbooks and fantasized about new victims. In 2004, stung by a newspaper article implying BTK had died or lost his nerve, Rader resurfaced with letters, crime-scene photos, and a floppy disk he believed was untraceable. Digital metadata and his own daughter's DNA ended the longest cat-and-mouse game in Kansas history, exposing the monster who had hidden in plain sight all along. - Sources:https://docs.google.com/document/d/1eTYeCoYyxm58DXXdoFbHQyWHlWbcH9iKGIefFcQToW4/edit?tab=t.0 Listen to our new show, "THE CONSPIRACY FILES"!: -Spotify - https://open.spotify.com/show/5IY9nWD2MYDzlSYP48nRPl -Apple Podcasts - https://podcasts.apple.com/us/podcast/the-conspiracy-files/id1752719844 -Amazon/Audible - https://music.amazon.com/podcasts/ab1ade99-740c-46ae-8028-b2cf41eabf58/the-conspiracy-files -Pandora - https://www.pandora.com/podcast/the-conspiracy-files/PC:1001089101 -iHeart - https://iheart.com/podcast/186907423/ -PocketCast - https://pca.st/dpdyrcca -CastBox - https://castbox.fm/channel/id6193084?country=us - Stay Connected: Join the Murder in America fam in our free Facebook Community for a behind-the-scenes look, more insights and current events in the true crime world: https://www.facebook.com/groups/4365229996855701 If you want even more Murder in America bonus content, including ad-free episodes, come join us on Patreon: https://www.patreon.com/murderinamerica Instagram: http://instagram.com/murderinamerica/ Facebook:https://www.facebook.com/people/Murder-in-America-Podcast/100086268848682/ Twitter: https://twitter.com/MurderInAmerica TikTok: https://www.tiktok.com/@theparanormalfiles and https://www.tiktok.com/@courtneybrowen Feeling spooky? Follow Colin as he travels state to state (and even country to country!) investigating claims of extreme paranormal activity and visiting famous haunted locations on The Paranormal Files Official Channel: https://www.youtube.com/c/TheParanormalFilesOfficialChannel - (c) BLOOD IN THE SINK PRODUCTIONS 2025 Learn more about your ad choices. Visit megaphone.fm/adchoices

In 1974, Wichita, Kansas was shaken by a series of brutal attacks inside family homes. Men, women, and children were bound, tortured, and killed by a predator who called himself BTK. For 17 years, he terrorized the community, claiming at least 10 victims and taunting police with disturbing letters that detailed his crimes. Then in 1991, the killings abruptly stopped, leaving law enforcement and the public to wonder if the killer had vanished forever. For more than a decade, there was silence. Then in 2004, BTK resurfaced with new messages, reigniting fear in Wichita. But that renewed need for attention would ultimately be his downfall, and by the following year, detectives had identified the killer as Dennis Rader, a father of two, a Scout leader, and a trusted member of his church council. Rader was the last person anyone suspected of being a sexual sadist serial killer, but once investigators began putting all the puzzle pieces together, it became clear that Rader's family-man persona was just a mask covering the monster beneath. Try our coffee!! - www.CriminalCoffeeCo.com Become a Patreon member -- > https://www.patreon.com/CrimeWeekly Shop for your Crime Weekly gear here --> https://crimeweeklypodcast.com/shop Youtube: https://www.youtube.com/c/CrimeWeeklyPodcast Website: CrimeWeeklyPodcast.com Instagram: @CrimeWeeklyPod Twitter: @CrimeWeeklyPod Facebook: @CrimeWeeklyPod ADS: 1. https://www.PDSDebt.com/CrimeWeekly - Get your FREE assessment and find the best option for you at PDS Debt! 2. https://www.EatIQBAR.com - Text WEEKLY to 64000 for 20% off ALL IQBAR products and FREE shipping! 3. https://www.Coyuchi.com/CrimeWeekly - Get 20% off your first order with Coyuchi! 4. https://www.Smalls.com/CrimeWeekly - Get 60% off your first order plus FREE shipping with Smalls! 5. https://www.SmartCredit.com/CrimeWeekly - Start your 7-day trial with Smart Credit for just $1!

Before he became the nightmare of Wichita, Kansas – the sadistic serial killer who taunted police with letters signed “BTK” – Dennis Rader was just a quiet, unassuming boy growing up in middle America. In this chilling episode, we go back to the beginning. This is the origin story of one of America's most infamous serial killers – the story of how Dennis Rader spent decades carefully constructing the perfect mask… This is the making of BTK. - Listen to our new show, "THE CONSPIRACY FILES"!: -Spotify - https://open.spotify.com/show/5IY9nWD2MYDzlSYP48nRPl -Apple Podcasts - https://podcasts.apple.com/us/podcast/the-conspiracy-files/id1752719844 -Amazon/Audible - https://music.amazon.com/podcasts/ab1ade99-740c-46ae-8028-b2cf41eabf58/the-conspiracy-files -Pandora - https://www.pandora.com/podcast/the-conspiracy-files/PC:1001089101 -iHeart - https://iheart.com/podcast/186907423/ -PocketCast - https://pca.st/dpdyrcca -CastBox - https://castbox.fm/channel/id6193084?country=us - Stay Connected: Join the Murder in America fam in our free Facebook Community for a behind-the-scenes look, more insights and current events in the true crime world: https://www.facebook.com/groups/4365229996855701 If you want even more Murder in America bonus content, including ad-free episodes, come join us on Patreon: https://www.patreon.com/murderinamerica Instagram: http://instagram.com/murderinamerica/ Facebook:https://www.facebook.com/people/Murder-in-America-Podcast/100086268848682/ Twitter: https://twitter.com/MurderInAmerica TikTok: https://www.tiktok.com/@theparanormalfiles and https://www.tiktok.com/@courtneybrowen Feeling spooky? Follow Colin as he travels state to state (and even country to country!) investigating claims of extreme paranormal activity and visiting famous haunted locations on The Paranormal Files Official Channel: https://www.youtube.com/c/TheParanormalFilesOfficialChannel - (c) BLOOD IN THE SINK PRODUCTIONS 2025 Learn more about your ad choices. Visit megaphone.fm/adchoices

SPONSORS: - Sign up for a $1 per month trial period at https://shopify.com/bears - If you're 21 or older, get 40% OFF your first order + free shipping @‌IndaCloud with code BEARS at https://inda.shop/BEARS ! #indacloudpod - Head to https://DRINKAG1.com/BEARS to get a FREE Welcome Kit with an AG1 Flavor Sampler and a bottle of Vitamin D3 plus K2, when you first subscribe! - Our listeners get 10% off their first month at https://betterhelp.com/bears ‌ Tom Segura returns to the cave with the one-and-only Kirk Fox, comedian, actor, and possibly a future Supermax inmate, depending on how you interpret this episode. The two dive into Kirk's accidental tennis-career-turned-acting path, his eccentric family upbringing (outdoor showers, blood-written memorials, and a grandma in a box), and his lifelong dream of becoming either an FBI profiler or a serial killer — whichever opportunity arrives first. From Waymo self-driving cars acting like drunk Uber drivers to territorial pissings, choke etiquette, BTK, Tommy Lynn Sells, Vince Champ the stand-up sex criminal, and a full breakdown of Supermax prison life, this episode spirals into a darkly hilarious masterclass on murder, consent, and why prison might actually be relaxing if you need more sleep. If the FBI is listening — it's all jokes. Probably. 2 Bears, 1 Cave Ep. 315 https://tomsegura.com/tour https://www.bertbertbert.com/tour https://store.ymhstudios.com Chapters 00:00:00 - Intro 00:01:34 - Tennis Legend Kirk Fox 00:08:40 - Charo Looks Like Bon Jovi 00:11:20 - Kirk's Home Life 00:17:53 - Golden Showers 00:24:46 - More Killers & AI Sex Robots 00:33:42 - Tommy Lynn Sells & Killing by Train 00:37:43 - The Next Killer in Our Friend Group 00:40:49 - Supermax Prison Fantasy 00:46:29 - My Dad Was A Serial Killer 00:52:38 - Vince Champ: The Sex Crime Comedian 00:58:21 - Kirk's FBI Dreams & Shamelessness 01:02:22 - Kirk & Tom Check Out Vince Champ's Comedy 01:06:07 - See You In Prison Learn more about your ad choices. Visit megaphone.fm/adchoices